Key Record Dates
ClinicalTrials.gov Identifier: | NCT03298867 |
---|---|
Brief Title: | Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study (OPTIC) |
First Submitted : | September 27, 2017 |
First Submitted that Met QC Criteria : | September 27, 2017 |
First Posted : | October 2, 2017 |
Results First Submitted : | February 14, 2020 |
Results First Submitted that Met QC Criteria : | March 2, 2020 |
Results First Posted : | March 10, 2020 |
Last Update Submitted that Met QC Criteria : | March 11, 2021 |
Last Update Posted : | April 8, 2021 |